This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Resources

Kerendia®(finerenone) Patient Support Materials

Useful, downloadable resources for patients initiated on Kerendia®(finerenone)

Kerendia Banner

Kerendia is indicated for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction (LVEF) ≥ 40% in adults. 

Kerendia is indicated for the treatment of chronic kidney disease (Stages 3 and 4 with albuminuria) associated with type 2 diabetes in adult patients.

Prescribing information for Kerendia can be found here.

Patient Booklets for Kerendia® (finerenone)

Digital leaflets for you to download and give to your patients who have been prescribed Kerendia. Please always ensure the patient reads the patient information leaflet (PIL) included in the Kerendia box for full details.

Abbreviations

LVEF - Left Ventricular Ejection Fraction

PP-KER-GB-0987 | June 2026